Bae, J., Shon, J., Kim, M., & Li, K. (2025). Pharmacogenetic Approaches to Optimize Bioequivalence Studies in Generic Drug Development. Journal of clinical pharmacology, 65(11), 1598-1608. https://doi.org/10.1002/jcph.70058
Chicago Style (17th ed.) CitationBae, Jihyun, Jihong Shon, Myong‐Jin Kim, and Karen Li. "Pharmacogenetic Approaches to Optimize Bioequivalence Studies in Generic Drug Development." Journal of Clinical Pharmacology 65, no. 11 (2025): 1598-1608. https://doi.org/10.1002/jcph.70058.
MLA (9th ed.) CitationBae, Jihyun, et al. "Pharmacogenetic Approaches to Optimize Bioequivalence Studies in Generic Drug Development." Journal of Clinical Pharmacology, vol. 65, no. 11, 2025, pp. 1598-1608, https://doi.org/10.1002/jcph.70058.
Warning: These citations may not always be 100% accurate.